Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Outdoor air pollution is a risk factor for prostate, colorectal, breast and endometrial cancers in some older adults.
Response rates ranged from 56% to 85% for several types of tumors with high HER2 expression.
Read about the new research presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Two clinical trials show promising results in treatment for endometrial cancer, the only gynecologic cancer with rising death rates.
Model using artificial intelligence accurately predicted the risk of distant recurrence in people with endometrial cancer.
Both Jemperli and Keytruda improved progression-free survival in late-stage clinical trials.
These websites offer education and support for people with uterine cancer, known as endometrial cancer when it starts in the uterine lining.
One project led by Bradley Corr, MD, uses the ORIEN resource to gather data on a specific mutation of endometrial cancer recurrence.
The virtual intervention was deemed appropriate and involved an acceptable time commitment.
The clinical trial used a combo of Verzenio and Femara in patients with recurrent endometrial cancer that’s estrogen receptor positive.
New data show 46,000 cancer cases could be prevented each year if Americans exercised least 5 hours each week.
Data from early clinical trials suggest new precision cancer treatments are on the horizon.
The immunotherapy is now approved to treat tumors with a specific genetic mutation anywhere in the body.
New checkpoint inhibitor Jemperli is approved for cancers with deficient mismatch repair mechanism for fixing damaged DNA.
IUDs were even more effective at preventing endometrial cancer in women with a precancerous condition.
Using birth control correlates to a small increase in breast cancer risk but a larger, permanent drop in ovarian and endometrial cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.